EVLV Evolv shares rise nearly 25 percent even as fourth quarter 2025 earnings lag consensus analyst expectations Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval State Street Technology Select Sector SPDR ETF XLK Poised for Upside Amid NVIDIAs 5 Trillion Market Cap Recapture and Broad Chip Sector Rally How does Filana Therapeutics FLNA make money Market Focus 20260427 Enviri Corporation NVRI Stock Consolidates Slow Drop 20260427